Clinical significance of a new oncogenic factor P5CR1 in gastric cancer.
Clinical significance of a new oncogenic factor P5CR1 in gastric cancer.
Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8248
Authors: Zhang CX, Li Y, Gong WH, Zhang J
Abstract
The article "Clinical significance of a new oncogenic factor P5CR1 in gastric cancer, by C.-X. Zhang, Y. Li, W.-H. Gong, J. Zhang, published in Eur Rev Med Pharmacol Sci 2020; 24(5): 2421-2427-DOI: 10.26355/eurrev_202003_20509-PMID: 32196593" has been withdrawn from the authors. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/20509.
PMID: 32894528 [PubMed - as supplied by publisher]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Gastric (Stomach) Cancer | Gastroenterology